Revvity, Inc. (RVTY) Misses Q3 EPS by 1c, updates guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Revvity (RVTY) sinks after third quarter results disappoint investors
October 30, 2023 11:11 AM EDTShares of health sciences company Revvity (NYSE: RVTY) plunged after it reported disappointing results for the third quarter of 2023 and updated its guidance. Management said the shortfall was due to an increasingly challenging end market environment.
Revvity reported third quarter adjusted EPS of $1.18 on revenue of $671 million. Consensus was expecting EPS of $1.19 and revenue of $695 million. The company said it expects... More
